Finance

Lists
VRCA:NASDAQ
Verrica Pharmaceuticals Inc
US$4,11
-1,67%
(-0,070) 1D
9 ຕ.ລ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VRCA...
Open
US$4,37
High
US$4,37
Low
US$4,06
Mkt. cap
70,60 ລ້ານ
Avg. vol.
76,18 ພັນ
Volume
46,55 ພັນ
52-wk high
US$9,82
52-wk low
US$3,28
EPS
US$-1,67
Beta
1,60
Shares outstanding
17,18 ລ້ານ
No. of employees
76
Open
US$4,37
High
US$4,37
Low
US$4,06
Mkt. cap
70,60 ລ້ານ
Avg. vol.
76,18 ພັນ
Volume
46,55 ພັນ
52-wk high
US$9,82
52-wk low
US$3,28
EPS
US$-1,67
Beta
1,60
Shares outstanding
17,18 ລ້ານ
No. of employees
76
News stories
From web sources and news partners
About Verrica Pharmaceuticals Inc
CEOJayson Rieger
Employees76
Founded2013
HeadquartersWest Chester, ເພນຊີນວາເນຍ, ສະຫະລັດ
SectorPharmaceutical industry
Analyst ratings
Based on 4 analysts giving stock ratings to VRCA in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for VRCA in the last 3 months.
Highest
Current US$4,11
US$20,00 (+386,62%)
Average
US$13,67 (+232,60%)
Lowest
US$9,00 (+118,98%)
Analyst
Recommendation
Action
Price target
Projected
Date
Thomas Flaten
Lake Street
Buy
Maintained
US$9,00
+119%
10/01/2026
Serge Belanger
Needham
Hold
Maintained
-
-
08/27/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
US$12,00
+192%
08/07/2026
Stacy Ku
TD Cowen
Buy
Reiterated
US$20,00
+386,6%
08/06/2026
Kemp Dolliver
Brookline Capital Markets
Buy
Upgraded
US$17,00
+313,6%
12/17/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
14,34 ລ້ານ
5,09 ລ້ານ
5,02 ລ້ານ
5,86 ລ້ານ
Cost of goods sold
3,31 ລ້ານ
3,92 ລ້ານ
4,75 ລ້ານ
6,91 ລ້ານ
Cost of revenue
3,31 ລ້ານ
3,92 ລ້ານ
4,75 ລ້ານ
6,91 ລ້ານ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9,40 ລ້ານ
8,12 ລ້ານ
9,99 ລ້ານ
10,35 ລ້ານ
Operating expense
9,40 ລ້ານ
8,12 ລ້ານ
9,99 ລ້ານ
10,35 ລ້ານ
Total operating expenses
12,72 ລ້ານ
12,04 ລ້ານ
14,74 ລ້ານ
17,26 ລ້ານ
Operating income
1,63 ລ້ານ
-6,95 ລ້ານ
-9,72 ລ້ານ
-11,40 ລ້ານ
Other non operating income
34,00 ພັນ
1,76 ລ້ານ
-8,00 ພັນ
-3,00 ພັນ
EBT including unusual items
-274,00 ພັນ
-8,07 ລ້ານ
-9,68 ລ້ານ
-13,15 ລ້ານ
EBT excluding unusual items
-274,00 ພັນ
-6,30 ລ້ານ
-9,68 ລ້ານ
-11,46 ລ້ານ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-274,00 ພັນ
-8,07 ລ້ານ
-9,68 ລ້ານ
-13,15 ລ້ານ
Net profit margin
-1,91%
-158,56%
-192,75%
-224,38%
Earnings per share
0,13
-0,51
-0,45
-0,48
Interest and investment income
159,00 ພັນ
205,00 ພັນ
201,00 ພັນ
111,00 ພັນ
Interest expense
-2,09 ລ້ານ
-1,31 ລ້ານ
-160,00 ພັນ
-164,00 ພັນ
Net interest expenses
-1,94 ລ້ານ
-1,11 ລ້ານ
41,00 ພັນ
-53,00 ພັນ
Depreciation and amortization charges
-
-
-
-
EBITDA
1,74 ລ້ານ
-6,83 ລ້ານ
-9,60 ລ້ານ
-11,27 ລ້ານ
Gain or loss from assets sale
68,00 ພັນ
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
ແອັບຂອງ Google